Randomised controlled trial to evaluate electronic Symptom Management using the Advanced Symptom Management System (ASyMS) Remote Technology for patients with cancers (FP7 Grant Agreement 602289)

The eSMART programme of work will demonstrate the effects of a real-time, mobile phone based, remote patient monitoring intervention on key patient outcomes and delivery of care provided to people with cancer during and after chemotherapy. Utilising the remote patient monitoring system, the Advanced Symptom Management System (ASyMS), will reduce the symptom burden experienced by patients receiving chemotherapy, improve their quality of life (QoL) during acute treatment and survivorship, and result in changes in clinical practice and improved delivery of care for patients with cancer.

eSMART is funded by the European Commission’s Seventh Framework Programme (2014-2020) Call FP7-HEALTH-2013-INNOVATION-1 Topic HEALTH.2013.2.4.1-3 - Investigator-driven supportive and palliative care clinical trials and observational studies under Grant Agreement No 602289.